Want to join the conversation?
$BDX 3Q15 Call: International revenues grew 6.6%, & medical segment grew 7.4%. Life Sciences grew 5.2%, reflecting strength in Pre-Analytical Systems & Diagnostics Systems. US revenues grew about 2%. In non-US developed markets, we saw a strong performance with Europe, Japan and Canada, all growing in mid-single digits on a currency neutral basis.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?